C. Ann Merrifield - 14 May 2025 Form 4 Insider Report for Lyra Therapeutics, Inc. (LYRA)

Reporting relationship: Director
Issuer ticker: LYRA
Reported as of: 14 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 May 2025, 16:30:45 UTC
Prior SEC filing: 14 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Jason Cavalier, Attorney-in-Fact for C. Ann Merrifield

Key filing fact

C. Ann Merrifield filed Form 4 for Lyra Therapeutics, Inc. (LYRA) on 16 May 2025.

Key facts

This page summarizes C. Ann Merrifield's Form 4 filing for Lyra Therapeutics, Inc. (LYRA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 16 May 2025, 16:30.

Change

Previous filing in this sequence was filed on 14 Jun 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001247224 Primary reporting owner

MERRIFIELD C ANN

Relationship: Director
Address: C/O LYRA THERAPEUTICS, INC., 480 ARSENAL WAY, WATERTOWN
Signature: /s/ Jason Cavalier, Attorney-in-Fact for C. Ann Merrifield
Signature date: 16 May 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LYRA transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +32,000
Change %
Price: $0.000000
Shares after: 32,000
Date: 14 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 32,000
Exercise price
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 100% on the earlier of (i) the day before the Issuer's next annual meeting, (ii) May 14, 2026 and (iii) upon a Change in Control as defined in the 2020 Incentive Award Plan.